About
Sciomics is a contract research and biomarker development company in Neckargemünd, Germany. It provides antibody microarray-based protein and post-translational modification profiling for pharma, biotech, and academic partners across disease areas. Its work supports biomarker discovery, pathway and mode-of-action analysis, preclinical model assessment, patient stratification, and therapy response prediction.
Services
scioDiscover Protein Profiling & Biomarker Discovery
High-throughput immuno-based protein profiling using antibody microarrays to quantify over 1,500 proteins from minimal sample volumes for biomarker discovery, pathway analysis, and pre-clinical research.
Protein Biomarker Discovery & Development
Comprehensive biomarker discovery and validation support from study design and sample selection through protein analysis, bioinformatics, and biomarker interpretation.
scioPhospho
Combined protein profiling and phosphorylation analysis in one assay with simultaneous detection of protein levels and phosphorylation status of more than 1,500 proteins.
scioUbi
Combined protein profiling and ubiquitination analysis in one assay with simultaneous detection of protein levels and ubiquitination status of more than 1,500 proteins.
scioCD
High-content profiling of cell surface markers, cytokines, and chemokines, including 141 unique CD molecules and 119 cytokine/chemokine analytes.
scioCyto
Multiplex cytokine and chemokine profiling on protein level for a range of sample types, with complete analysis from protein extraction to study report.
Sample type profiling
Protein analysis and biomarker discovery for plasma/serum, CSF, ISF, urine, saliva, tissue lysates, cell lysates, cell culture supernatants, organoids, and other protein-containing samples.
Data analysis and interpretation
Bioinformatic analysis, protein interaction and pathway network mapping, functional annotation, biological/pathway classification, and scientific study reporting.
scioDiscover protein profiling
High-throughput protein profiling for biomarker discovery, pathway analysis, disease mechanism studies, and preclinical drug development using antibody microarrays.
scioDiscover biomarker discovery
Protein biomarker discovery and development service with study design, sample analysis, data analysis, interpretation, and validation support.
- Turnaround
- Within few weeks
- What to send
- Minimal sample volumes · 10 μL plasma/serum · Native sample matrices (non-fractionated / non-depleted) · Minute sample amounts · Plasma · Serum · Cerebrospinal fluid (CSF) · Interstitial fluid (ISF) · Urine · Saliva · Tissue lysates · Cell lysates / cultured cells
3 more
Cell culture supernatants · Organoids · PBMC
Capabilities
- Assays and studies
- Antibodies · Rodent models · In vivo · High-throughput immuno-based protein profiling · Antibody microarray profiling · Phosphoproteomics · Ubiquitination profiling · Multiplex cytokine profiling · Cell surface marker profiling · Antibody microarray · Affinity proteomics · Immuno-based proteomics
- Scale and capacity
- Over 1,500 proteins per assay · Up to 1,400 proteins in scioUbi · Up to 119 cytokines and chemokines in scioCyto · 349 proteins in scioCD · Simultaneous quantification of over 1,500 proteins · More than 1,400 proteins in a single assay · > 1,500 proteins · 349 different proteins · 4 technical replicates · CV <10% · > 6,000 data points per sample · >12,000 data points for each sample
- Therapeutic areas
- Precision medicine · Oncology · Neurological disorders · Organ failure · Infectious diseases · Kidney injury · Inflammation · Acute kidney injury · Cancer · Dengue fever · COVID-19 · Endometrial cancer
2 more
Endometriosis · Parkinson’s disease
Instruments and platforms
- Antibody microarray platform
- scioDiscover microarray platform
- scioDiscover platform
- scioPhospho platform
- scioUbi platform
- scioCD affinity proteomics platform
Modalities and species
- Modalities
- Antibody
- Species and models
- Human · Murine · Organoids · Cell cultures · Cell lysates · Tissue lysates · Cell culture supernatants · Human biospecimens · Animal models · Rat · Organoid models · Cells
Industries served
- Pharma
- Biotech
- Academic research
Company
- Type
- CRO
- Quality
- CV <10% (reproducibility) · 4 technical replicates (per target protein and sample) · high sensitivity and reproducibility · CV < 10% (scioPhospho and scioUbi)
Locations
- Based in
- Neckargemünd, Germany
- Sites
- Neckargemünd, Germany
- Serves
- worldwide
Contacts
- General enquiry
- info@sciomics.de on their site
- Phone
- +49 6223 9689-500
Similar labs
Work here? Claim this listing